BlueWhale Bio

Philadelphia, United States

BlueWhale Bio is committed to advancing cell-based therapeutics through manufacturing innovation.

$5.0M raised

Oct 2025

Venture - Series Unknown

Biotechnology Manufacturing

Top Investors

Novalis LifeSciences Marshall Wace Danaher Ventures Penn Medicine Co-Investment Program

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about BlueWhale Bio

How much funding has BlueWhale Bio raised?

BlueWhale Bio has raised $5.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in October 2025.

Who are BlueWhale Bio's investors?

BlueWhale Bio's investors include Novalis LifeSciences, Marshall Wace, Danaher Ventures, Penn Medicine Co-Investment Program.

Where is BlueWhale Bio headquartered?

BlueWhale Bio is headquartered in Philadelphia, United States.

What does BlueWhale Bio do?

BlueWhale Bio is committed to advancing cell-based therapeutics through manufacturing innovation.

What stage is BlueWhale Bio at?

BlueWhale Bio is at the Venture - Series Unknown stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated October 16, 2025.

MLA

"BlueWhale Bio — Funding & Investors." VCBacked, October 16, 2025, https://www.vcbacked.co/company/bluewhale-bio. Accessed July 2, 2026.

APA

VCBacked. (2025). BlueWhale Bio — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/bluewhale-bio

Wikipedia (cite web)

{{cite web |title=BlueWhale Bio — Funding & Investors |url=https://www.vcbacked.co/company/bluewhale-bio |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated October 16, 2025.

Similar Companies in Biotechnology

View all

Renaissance BioScience

Vancouver$599K

Allterum Therapeutics

Advanced Microbiome Interventions

Amsterdam$300K